Validity of hepatic steatosis indices for prediction of non-alcoholic hepatic steatosis in type 1 diabetic patients

被引：0
|
作者：
Sokolovska, J. [1 ]
Sviklane, L. [1 ]
Olmane, E. [2 ]
Dzerve, Z. [1 ]
Kupcs, K. [2 ]
机构：
[1] Univ Latvia, Lab Personalized Med, Riga, Latvia
[2] Pauls Stradins Univ Hosp, Magnet Resonance Ctr DiaMed, Riga, Latvia
来源：
DIABETOLOGIA | 2017年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1244
引用
收藏
页码：S573 / S573
页数：1
相关论文
共 50 条
  • [21] Effect of severity of steatosis as assessed ultrasonographically on hepatic vascular indices in non-alcoholic fatty liver disease
    Mohammadi, Afshin
    Ghasemi-rad, Mohammad
    Zahedi, Hengameh
    Toldi, Gergely
    Alinia, Tahereh
    MEDICAL ULTRASONOGRAPHY, 2011, 13 (03) : 200 - 206
  • [22] Pathogenesis of alcoholic hepatic steatosis
    Simpson, KJ
    ADDICTION BIOLOGY, 1996, 1 (04) : 363 - 370
  • [23] Linagliptin alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis
    Thomas Klein
    Masato Fujii
    Jan Sandel
    Yuichiro Shibazaki
    Kyoko Wakamatsu
    Michael Mark
    Hiroyuki Yoneyama
    Medical Molecular Morphology, 2014, 47 : 137 - 149
  • [24] Pitavastatin inhibits hepatic steatosis and fibrosis in non-alcoholic steatohepatitis model rats
    Miyaki, Tomokatsu
    Nojiri, Shunsuke
    Shinkai, Noboru
    Kusakabe, Atsunori
    Matsuura, Kentaro
    Iio, Etsuko
    Takahashi, Satoru
    Yan, Ge
    Ikeda, Kazuo
    Joh, Takashi
    HEPATOLOGY RESEARCH, 2011, 41 (04) : 375 - 385
  • [25] Linagliptin alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis
    Klein, Thomas
    Fujii, Masato
    Sandel, Jan
    Shibazaki, Yuichiro
    Wakamatsu, Kyoko
    Mark, Michael
    Yoneyama, Hiroyuki
    MEDICAL MOLECULAR MORPHOLOGY, 2014, 47 (03) : 137 - 149
  • [26] Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease
    Luukkonen, Panu K.
    Zhou, You
    Sadevirta, Sanja
    Leivonen, Marja
    Arola, Johanna
    Oresic, Matej
    Hyotylainen, Tuulia
    Yki-Jarvinen, Hannele
    JOURNAL OF HEPATOLOGY, 2016, 64 (05) : 1167 - 1175
  • [27] Decreased Hepatic Lactotransferrin Induces Hepatic Steatosis in Chronic Non-Alcoholic Fatty Liver Disease Model
    Lee, Sungmin
    Son, Beomseok
    Jeon, Jaewan
    Park, Gaeul
    Kim, Hyunwoo
    Kang, Hyunkoo
    Youn, HyeSook
    Jo, Sunmi
    Song, Jie-Young
    Youn, BuHyun
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 47 (06) : 2233 - 2249
  • [28] NO DIFFUSE HEPATIC STEATOSIS IN TYPE 1 DIABETIC PATIENTS RECEIVING INTRAPERITONEAL INSULINOTHERAPY
    Baillot-Rudoni, S.
    Petit, J. M.
    Buffier, P.
    Farret, A.
    Bouillet, B.
    Valliant, G.
    Verges, B.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 : A50 - A50
  • [29] Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan
    Tran Thi Khanh Tuong
    Dang Khoa Tran
    Pham Quang Thien Phu
    Tong Nguyen Diem Hong
    Thien Chu Dinh
    Dinh Toi Chu
    DIAGNOSTICS, 2020, 10 (03)
  • [30] NON-ALCOHOLIC STEATOSIS OF THE LIVER
    BOUSTIERE, C
    GAUTHIER, A
    PRESSE MEDICALE, 1985, 14 (20): : 1147 - 1150
12345